May 21, 2024
The numbers of cancer cases and deaths are rising in Canada, even as overall rates of cancer incidence and mortality continue to decline, new research suggested. […]
May 20, 2024
TOPLINE: HER2DX, a standardized 27-gene expression test, appears to predict event-free survival in patients with early-stage HER2+ breast cancer, and the test could be used to […]
May 20, 2024
LONDON (Reuters) -An infected blood scandal in Britain was no accident but the fault of doctors and a succession of governments that led to 3,000 deaths […]
May 17, 2024
BRCA is no longer the only gene that identifies hereditary breast cancer (BC) syndromes. Pathogenic variants of CDH1 identify a form of hereditary lobular BC (HLBC) […]
May 17, 2024
A relatively high percentage of men in their 70s and 80s, as well those determined to have a limited life expectancy, report receiving prostate cancer screening, […]
May 17, 2024
A major trial has demonstrated that low risk prostate cancers do not fare better by adding 6 months of hormone treatment to radiotherapy following radical prostatectomy, […]
May 17, 2024
TOPLINE: A minority of patients with metastatic castration-resistant prostate cancer (mCRPC) in the United States undergo genetic testing for homologous recombination repair (HRR) mutations, despite the […]
May 16, 2024
The US Food and Drug Administration has granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen) for extensive-stage small cell lung cancer (SCLC) with disease progression on or […]
May 16, 2024
Adding atezolizumab to chemotherapy in patients with anti–programmed death ligand 1 (PD-L1)–positive triple-negative breast cancer (TNBC) who have relapsed within 12 months of their last curative […]